Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$306.88 - $380.0 $2,455 - $3,040
-8 Reduced 0.23%
3,513 $1.33 Million
Q3 2023

Nov 07, 2023

BUY
$315.92 - $397.36 $131,106 - $164,904
415 Added 13.36%
3,521 $1.12 Million
Q2 2023

Aug 07, 2023

BUY
$346.15 - $392.09 $132,921 - $150,562
384 Added 14.11%
3,106 $1.19 Million
Q1 2023

May 08, 2023

BUY
$323.56 - $373.36 $397,978 - $459,232
1,230 Added 82.44%
2,722 $1.02 Million
Q4 2022

Feb 07, 2023

BUY
$248.67 - $334.17 $95,489 - $128,321
384 Added 34.66%
1,492 $493,000
Q3 2022

Nov 08, 2022

BUY
$263.81 - $337.27 $44,056 - $56,324
167 Added 17.75%
1,108 $293,000
Q2 2022

Aug 08, 2022

BUY
$301.4 - $428.42 $48,525 - $68,975
161 Added 20.64%
941 $294,000
Q1 2022

May 03, 2022

BUY
$379.46 - $424.54 $295,978 - $331,141
780 New
780 $326,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.